The combinatorial diversity of KIR and HLA class I allotypes in Peninsular Malaysia
Sudan Tao, Katherine M. Kichula, Genelle F. Harrison, Ticiana D.J. Farias, William Palmer, Laura Ann Leaton, Che Ghazali Norul Hajar, Zefarina Zulkafli, Hisham Atan Edinur, Faming Zhu, Paul J. Norman
Abstract
Summary Killer cell immunoglobulin‐like receptors ( KIRs ) interact with polymorphic human leucocyte antigen ( HLA ) class I molecules, modulating natural killer (NK) cell functions and affecting both the susceptibility and outcome of immune‐mediated diseases. The KIR locus is highly diverse in gene content, copy number and allelic polymorphism within individuals and across geographical populations. To analyse currently under‐represented Asian and Pacific populations, we investigated the combinatorial diversity of KIR and HLA class I in 92 unrelated Malay and 75 Malaysian Chinese individuals from the Malay Peninsula. We identified substantial allelic and structural diversity of the KIR locus in both populations and characterized novel variations at each analysis level. The Malay population is more diverse than Malay Chinese, likely representing a unique history including admixture with immigrating populations spanning several thousand years. Characterizing the Malay population are KIR haplotypes with large structural variants present in 10% individuals, and KIR and HLA alleles previously identified in Austronesian populations. Despite the differences in ancestries, the proportion of HLA allotypes that serve as KIR ligands is similar in each population. The exception is a significantly reduced frequency of interactions of KIR2DL1 with C2 + HLA‐C in the Malaysian Chinese group, caused by the low frequency of C2 + HLA. One likely implication is a greater protection from preeclampsia, a pregnancy disorder associated with KIR2DL1, which shows higher incidence in the Malay than in the Malaysian Chinese. This first complete, high‐resolution, characterization of combinatorial diversity of KIR and HLA in Malaysians will form a valuable reference for future clinical and population studies.